Clinical Trials Browser

AMG 757 × 30 days × Clear all

NCT05361395 2026-03-03

First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Phase 1 Active not recruiting

Bites and Stings, Lung Neoplasms

NCT06745323 2026-03-03

DeLLphi-309

Phase 2 Active not recruiting

Small Cell Lung Carcinoma

NCT06117774 2026-02-27

DeLLphi-306

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT07005128 2026-02-27

DeLLphi-312

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT07037758 2026-02-20

DeLLphi-311

Phase 1 Recruiting

Extensive Stage Small Cell Lung Cancer